Theralase Anti-Cancer Technology Picks Up Steam
There are many different approaches to treating cancer, ranging from Roche Holding Ltd.'s monoclonal antibody Perjeta to Merck & Co. Inc.'s immunotherapy Keytruda. While both of these drugs have made great strides over the past couple years, some companies are looking beyond the standard ways of combatting cancer and pioneering entirely new approaches to treatment.